サマリー

経腸栄養法は、患者に栄養を供給するプロセスである。このプロセスでは、液体サプリメントや日常必要な栄養素がチューブの助けを借りて患者に供給される。
市場の分析および洞察。感染予防と経腸アクセスの世界市場
COVID-19の大流行により、世界の感染予防と経腸アクセスの市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に感染予防と経腸アクセスの世界市場の％を占めた経腸栄養ポンプは、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、オンコロジーセグメントは、この予測期間を通して％CAGRに変更されています。
そのような限られた経口摂取量を持つ術後患者の存在、重症膵炎や慢性疾患の発生率の増加、高齢者人口の増加、技術の進歩、および未熟児出産の増加などの要因は、市場の成長を推進しています。
さらに、発展途上国におけるRandD投資の増加や未開拓の市場機会が、市場成長の機会を増大させています。

世界の感染予防と経腸アクセスの範囲とセグメント
感染予防および経腸アクセス市場は、タイプ別および用途別に区分されます。世界の感染予防と経腸アクセス市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てます。

タイプ別セグメント
経腸栄養補給ポンプ
経腸栄養チューブ
投与用リザーバー
ギブセット
経腸用シリンジ
用途別セグメント
オンコロジー
胃腸病学
糖尿病
神経系疾患
代謝亢進症
その他
会社別
クックメディカル
メドトロニック・プロック
ボストン・サイエンティフィック株式会社
株式会社コンメッド
コーパックメッドシステムズ
CRバルド
ALCORサイエンティフィック
パシフィック・ホスピタル・サプライ
テレフレックス・インコーポレイテッド
Vygon SA
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Infection Prevention and Enteral Access Product Introduction
1.2 Market by Type
1.2.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Enteral Feeding Pumps
1.2.3 Enteral Feeding Tubes
1.2.4 Administration Reservoirs
1.2.5 Giving Sets
1.2.6 Enteral Syringes
1.3 Market by Application
1.3.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Gastroenterology
1.3.4 Diabetes
1.3.5 Neurological Disorders
1.3.6 Hypermetabolism
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Infection Prevention and Enteral Access Sales Estimates and Forecasts 2017-2028
2.2 Global Infection Prevention and Enteral Access Revenue Estimates and Forecasts 2017-2028
2.3 Global Infection Prevention and Enteral Access Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Infection Prevention and Enteral Access Sales by Region
2.4.1 Global Infection Prevention and Enteral Access Sales by Region (2017-2022)
2.4.2 Global Sales Infection Prevention and Enteral Access by Region (2023-2028)
2.5 Global Infection Prevention and Enteral Access Revenue by Region
2.5.1 Global Infection Prevention and Enteral Access Revenue by Region (2017-2022)
2.5.2 Global Infection Prevention and Enteral Access Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Infection Prevention and Enteral Access Sales by Manufacturers
3.1.1 Global Top Infection Prevention and Enteral Access Manufacturers by Sales (2017-2022)
3.1.2 Global Infection Prevention and Enteral Access Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infection Prevention and Enteral Access in 2021
3.2 Global Infection Prevention and Enteral Access Revenue by Manufacturers
3.2.1 Global Infection Prevention and Enteral Access Revenue by Manufacturers (2017-2022)
3.2.2 Global Infection Prevention and Enteral Access Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Infection Prevention and Enteral Access Revenue in 2021
3.3 Global Infection Prevention and Enteral Access Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Infection Prevention and Enteral Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Infection Prevention and Enteral Access Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Infection Prevention and Enteral Access Sales by Type
4.1.1 Global Infection Prevention and Enteral Access Historical Sales by Type (2017-2022)
4.1.2 Global Infection Prevention and Enteral Access Forecasted Sales by Type (2023-2028)
4.1.3 Global Infection Prevention and Enteral Access Sales Market Share by Type (2017-2028)
4.2 Global Infection Prevention and Enteral Access Revenue by Type
4.2.1 Global Infection Prevention and Enteral Access Historical Revenue by Type (2017-2022)
4.2.2 Global Infection Prevention and Enteral Access Forecasted Revenue by Type (2023-2028)
4.2.3 Global Infection Prevention and Enteral Access Revenue Market Share by Type (2017-2028)
4.3 Global Infection Prevention and Enteral Access Price by Type
4.3.1 Global Infection Prevention and Enteral Access Price by Type (2017-2022)
4.3.2 Global Infection Prevention and Enteral Access Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Infection Prevention and Enteral Access Sales by Application
5.1.1 Global Infection Prevention and Enteral Access Historical Sales by Application (2017-2022)
5.1.2 Global Infection Prevention and Enteral Access Forecasted Sales by Application (2023-2028)
5.1.3 Global Infection Prevention and Enteral Access Sales Market Share by Application (2017-2028)
5.2 Global Infection Prevention and Enteral Access Revenue by Application
5.2.1 Global Infection Prevention and Enteral Access Historical Revenue by Application (2017-2022)
5.2.2 Global Infection Prevention and Enteral Access Forecasted Revenue by Application (2023-2028)
5.2.3 Global Infection Prevention and Enteral Access Revenue Market Share by Application (2017-2028)
5.3 Global Infection Prevention and Enteral Access Price by Application
5.3.1 Global Infection Prevention and Enteral Access Price by Application (2017-2022)
5.3.2 Global Infection Prevention and Enteral Access Price Forecast by Application (2023-2028)
6 North America
6.1 North America Infection Prevention and Enteral Access Market Size by Type
6.1.1 North America Infection Prevention and Enteral Access Sales by Type (2017-2028)
6.1.2 North America Infection Prevention and Enteral Access Revenue by Type (2017-2028)
6.2 North America Infection Prevention and Enteral Access Market Size by Application
6.2.1 North America Infection Prevention and Enteral Access Sales by Application (2017-2028)
6.2.2 North America Infection Prevention and Enteral Access Revenue by Application (2017-2028)
6.3 North America Infection Prevention and Enteral Access Market Size by Country
6.3.1 North America Infection Prevention and Enteral Access Sales by Country (2017-2028)
6.3.2 North America Infection Prevention and Enteral Access Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Infection Prevention and Enteral Access Market Size by Type
7.1.1 Europe Infection Prevention and Enteral Access Sales by Type (2017-2028)
7.1.2 Europe Infection Prevention and Enteral Access Revenue by Type (2017-2028)
7.2 Europe Infection Prevention and Enteral Access Market Size by Application
7.2.1 Europe Infection Prevention and Enteral Access Sales by Application (2017-2028)
7.2.2 Europe Infection Prevention and Enteral Access Revenue by Application (2017-2028)
7.3 Europe Infection Prevention and Enteral Access Market Size by Country
7.3.1 Europe Infection Prevention and Enteral Access Sales by Country (2017-2028)
7.3.2 Europe Infection Prevention and Enteral Access Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Infection Prevention and Enteral Access Market Size by Type
8.1.1 Asia Pacific Infection Prevention and Enteral Access Sales by Type (2017-2028)
8.1.2 Asia Pacific Infection Prevention and Enteral Access Revenue by Type (2017-2028)
8.2 Asia Pacific Infection Prevention and Enteral Access Market Size by Application
8.2.1 Asia Pacific Infection Prevention and Enteral Access Sales by Application (2017-2028)
8.2.2 Asia Pacific Infection Prevention and Enteral Access Revenue by Application (2017-2028)
8.3 Asia Pacific Infection Prevention and Enteral Access Market Size by Region
8.3.1 Asia Pacific Infection Prevention and Enteral Access Sales by Region (2017-2028)
8.3.2 Asia Pacific Infection Prevention and Enteral Access Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Infection Prevention and Enteral Access Market Size by Type
9.1.1 Latin America Infection Prevention and Enteral Access Sales by Type (2017-2028)
9.1.2 Latin America Infection Prevention and Enteral Access Revenue by Type (2017-2028)
9.2 Latin America Infection Prevention and Enteral Access Market Size by Application
9.2.1 Latin America Infection Prevention and Enteral Access Sales by Application (2017-2028)
9.2.2 Latin America Infection Prevention and Enteral Access Revenue by Application (2017-2028)
9.3 Latin America Infection Prevention and Enteral Access Market Size by Country
9.3.1 Latin America Infection Prevention and Enteral Access Sales by Country (2017-2028)
9.3.2 Latin America Infection Prevention and Enteral Access Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Infection Prevention and Enteral Access Market Size by Type
10.1.1 Middle East and Africa Infection Prevention and Enteral Access Sales by Type (2017-2028)
10.1.2 Middle East and Africa Infection Prevention and Enteral Access Revenue by Type (2017-2028)
10.2 Middle East and Africa Infection Prevention and Enteral Access Market Size by Application
10.2.1 Middle East and Africa Infection Prevention and Enteral Access Sales by Application (2017-2028)
10.2.2 Middle East and Africa Infection Prevention and Enteral Access Revenue by Application (2017-2028)
10.3 Middle East and Africa Infection Prevention and Enteral Access Market Size by Country
10.3.1 Middle East and Africa Infection Prevention and Enteral Access Sales by Country (2017-2028)
10.3.2 Middle East and Africa Infection Prevention and Enteral Access Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Cook Medical
11.1.1 Cook Medical Corporation Information
11.1.2 Cook Medical Overview
11.1.3 Cook Medical Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Cook Medical Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cook Medical Recent Developments
11.2 Medtronic Plc
11.2.1 Medtronic Plc Corporation Information
11.2.2 Medtronic Plc Overview
11.2.3 Medtronic Plc Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Medtronic Plc Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medtronic Plc Recent Developments
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Corporation Information
11.3.2 Boston Scientific Corporation Overview
11.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boston Scientific Corporation Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boston Scientific Corporation Recent Developments
11.4 CONMED Corporation
11.4.1 CONMED Corporation Corporation Information
11.4.2 CONMED Corporation Overview
11.4.3 CONMED Corporation Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 CONMED Corporation Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CONMED Corporation Recent Developments
11.5 CORPAK MedSystems
11.5.1 CORPAK MedSystems Corporation Information
11.5.2 CORPAK MedSystems Overview
11.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CORPAK MedSystems Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CORPAK MedSystems Recent Developments
11.6 CR Bard
11.6.1 CR Bard Corporation Information
11.6.2 CR Bard Overview
11.6.3 CR Bard Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CR Bard Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CR Bard Recent Developments
11.7 ALCOR Scientific
11.7.1 ALCOR Scientific Corporation Information
11.7.2 ALCOR Scientific Overview
11.7.3 ALCOR Scientific Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ALCOR Scientific Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ALCOR Scientific Recent Developments
11.8 Pacific Hospital Supply
11.8.1 Pacific Hospital Supply Corporation Information
11.8.2 Pacific Hospital Supply Overview
11.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pacific Hospital Supply Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pacific Hospital Supply Recent Developments
11.9 Teleflexorporated
11.9.1 Teleflexorporated Corporation Information
11.9.2 Teleflexorporated Overview
11.9.3 Teleflexorporated Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teleflexorporated Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teleflexorporated Recent Developments
11.10 Vygon SA
11.10.1 Vygon SA Corporation Information
11.10.2 Vygon SA Overview
11.10.3 Vygon SA Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vygon SA Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vygon SA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Infection Prevention and Enteral Access Industry Chain Analysis
12.2 Infection Prevention and Enteral Access Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Infection Prevention and Enteral Access Production Mode & Process
12.4 Infection Prevention and Enteral Access Sales and Marketing
12.4.1 Infection Prevention and Enteral Access Sales Channels
12.4.2 Infection Prevention and Enteral Access Distributors
12.5 Infection Prevention and Enteral Access Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Infection Prevention and Enteral Access Industry Trends
13.2 Infection Prevention and Enteral Access Market Drivers
13.3 Infection Prevention and Enteral Access Market Challenges
13.4 Infection Prevention and Enteral Access Market Restraints
14 Key Findings in The Global Infection Prevention and Enteral Access Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer